Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

被引：124

作者：

Martin, RM ^{[1
]}

Kapoor, KV

Wilton, LV

Mann, RD

机构：

[1] Drug Safety Res Unit, Southampton SO31 1AA, Hants, England

[2] Univ Southampton, Fac Med Hlth & Biol Sci, Sch Med, Southampton SO16 7PX, Hants, England

来源：

关键词：

D O I：

10.1136/bmj.317.7151.119

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：119 / 120

页数：2

共 5 条

BELTON, KJ ;

LEWIS, SC ;

PAYNE, S ;

RAWLINS, MD ;

WOOD, SM .

[2] REVIEW OF YELLOW CARDS - 1986 AND 1987 [J].

BEM, JL ;

MANN, RD ;

RAWLINS, MD .

[3]

*JOINT FORM COMM, 1997, BRIT NATL FORMULARY, P10

[4]

LUMLEY C E, 1986, Pharmaceutical Medicine (London), V1, P205

[5]

RAWLINS MD, 1993, BR J CLIN PHARM, V35, P590